A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
Study Identifier
150998-005
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Statistical Analysis Plan
Available Language(s): English
Protocol
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
50+ years
Protocol Summary
This is a safety and efficacy study of abicipar pegol in participants with neovascular age-related macular degeneration.
Study Locations
Location
Status
Location
Retinal Research Institute, LLC
Phoenix, Arizona, United States, 85014
Status
Not applicable
Location
Associated Retina Consultants, Ltd.
Phoenix, Arizona, United States, 85020
Status
Not applicable
Location
Arizona Retina and Vitreous Consultants
Phoenix, Arizona, United States, 85021
Status
Not applicable
Location
Retina Associates Southwest, P.C.
Tucson, Arizona, United States, 85710
Status
Not applicable
Location
The Retina Partners
Encino, California, United States, 91436
Status
Not applicable
Location
Retina Consultants of Orange County
Fullerton, California, United States, 92835
Status
Not applicable
Showing {first} - {last} of {total} Results